Epithelioid sarcoma overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 18: Line 18:
The most potent risk factor in the development of epithelioid sarcoma is the presence of [[family history]] of epithelioid sarcoma.
The most potent risk factor in the development of epithelioid sarcoma is the presence of [[family history]] of epithelioid sarcoma.
==Natural history, Complications and Prognosis==
==Natural history, Complications and Prognosis==
The symptoms of epithelioid sarcoma usually develop in the second decade of life, and start with symptoms such as mass. Epitheliod sarcoma has a tendency for lymph node metastasis. The most common sites of epithelioid m
The symptoms of epithelioid sarcoma usually develop in the second decade of life, and start with symptoms such as mass. Epitheliod sarcoma has a tendency for lymph node metastasis. The most common sites of epithelioid metastasis include lungs, lymph nodes, and scalp. Common complications of epithelioid sarcoma include metastasis, nerve compression, and numbness. The prognosis of epithelioid sarcoma is good for females.
==Staging==
==Staging==
The staging for epithelioid sarcoma takes into account size and location of the primary tumor, lymph node involvement, presence and location of metastasis, and histologic grade.
The staging for epithelioid sarcoma takes into account size and location of the primary tumor, lymph node involvement, presence and location of metastasis, and histologic grade.

Revision as of 14:50, 19 February 2016

Epithelioid sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Epithelioid sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

MRI

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epithelioid sarcoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epithelioid sarcoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epithelioid sarcoma overview

CDC on Epithelioid sarcoma overview

Epithelioid sarcoma overview in the news

Blogs on Epithelioid sarcoma overview

Directions to Hospitals Treating Epithelioid sarcoma

Risk calculators and risk factors for Epithelioid sarcoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]; Ammu Susheela, M.D. [3]

Overview

Epithelioid sarcoma is a rare mesenchymal soft tissue tumor with an epithelioid pattern. It often occurs in the extremities of young people. Diagnosis is often delayed because of the unusual nature of the tumor.

Historical Perspective

Epithelioid sarcoma was first discovered by Dr. J. Laskowski, a polish doctor, in 1961 following the description of a clinical entity called sarcoma aponeuroticum due to involvement of aponeurosis. Enzinger coined the term epithelioid sarcoma in 1970.

Pathophysiology

Mutations in the SMARCB1 gene cause epithelioid sarcoma. On gross pathology, solid, multinodular mass, glistening gray tan appearance, and multiple areas of hemorrhage and necrosis are characteristic findings of epithelioid sarcoma. On microscopic histopathological analysis, central necrosis surrounded by bland, polygonal cells with eosinophilic cytoplasm and peripheral spindling, desmoplasia, focal calcification, or metaplastic ossification are characteristic findings of epithelioid sarcoma.

Causes

Mutations in the SMARCB1 gene cause epithelioid sarcoma.

Differentiating Epithelioid sarcoma from other Diseases

Epithelioid sarcoma must be differentiated from synovial sarcoma, wart, ganglion cysts, rhabdomyosarcoma, and clear cell sarcoma.

Epidemiology and Demographics

The epithelioid sarcoma is a very rare disease. The incidence of epithelioid sarcoma increases between ages of 10 and 39 and the average age of presentation was 27 years. Males are more commonly affected with epithelioid sarcoma than female. Epithelioid sarcoma of upper extremity usually affects individuals of the Caucasian race.

Risk Factors

The most potent risk factor in the development of epithelioid sarcoma is the presence of family history of epithelioid sarcoma.

Natural history, Complications and Prognosis

The symptoms of epithelioid sarcoma usually develop in the second decade of life, and start with symptoms such as mass. Epitheliod sarcoma has a tendency for lymph node metastasis. The most common sites of epithelioid metastasis include lungs, lymph nodes, and scalp. Common complications of epithelioid sarcoma include metastasis, nerve compression, and numbness. The prognosis of epithelioid sarcoma is good for females.

Staging

The staging for epithelioid sarcoma takes into account size and location of the primary tumor, lymph node involvement, presence and location of metastasis, and histologic grade.

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Medical Therapy

Surgery

References


Template:WikiDoc Sources